Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2

Conditions: Leukemia
Adult Lymphoblastic Lymphoma
Adult Acute Lymphoblastic Leukemia
Leukemia, Lymphoblastic
Leukemia, T Cell
Lymphoblastic Lymphoma
Leukemia, Acute
Lymphoblastic Leukemia

Interventions: Drug: Dexamethasone
Drug: vincristine
Drug: Cyclophosphamide
Drug: Idarubicin
Drug: Pegaspargase
Drug: Adriamycin
Drug: Methotrexate
Drug: 6-mercaptopurine.
Drug: Etoposide
Drug: Cytarabine
Procedure: Bone marrow aspiration
Procedure: Intrathecal injection
Radiation: Radiation therapy
Genetic: NGS
Procedure: allogeneic hematopoietic stem cell transplantation
Diagnostic Test: Flow-MRD
Diagnostic Test: FISH
Diagnostic Test: Flow immunophenotyping
Diagnostic Test: Karyotyping
Drug: Chidamide
Diagnostic Test: PET-CT scan

First Posted Date: 2018-06-21

Last Posted Date: 2018-06-21

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 80

Registration Number: NCT03564704

Locations: 🇨🇳
Department of Hematology, Nanfang Hospital, Guangzhou, Guangdong, China

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Phase 2

Conditions: Leukemia, B-cell
Leukemia
Leukemia, Acute
Leukemia, Lymphoblastic

Interventions: Drug: Chidamide
Drug: Dasatinib

First Posted Date: 2018-06-20

Last Posted Date: 2022-07-01

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 120

Registration Number: NCT03564470

Locations: 🇨🇳
Department of Hematology, Nanfang Hospital, Guangzhou, Guangdong, China

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

Phase 2

Conditions: Leukemia, Acute
Leukemia, T Cell
Leukemia, Lymphoblastic

Interventions: Drug: Chidamide
Drug: Dexamethasone
Drug: vincristine
Drug: Cyclophosphamide
Drug: Idarubicin
Drug: Pegaspargase
Drug: Adriamycin
Drug: Methotrexate
Drug: 6-Mercaptopurine
Drug: Etoposide
Drug: Cytarabine
Procedure: Bone marrow aspiration
Procedure: Intrathecal injection
Radiation: Radiation therapy
Genetic: NGS
Procedure: allogeneic hematopoietic stem cell transplantation
Diagnostic Test: Flow-MRD
Diagnostic Test: FISH
Diagnostic Test: Flow immunophenotyping
Diagnostic Test: Karyotyping

First Posted Date: 2018-06-12

Last Posted Date: 2018-06-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 70

Registration Number: NCT03553238

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Trial Comparing Quadratus Lumborum Block (QLB) and Paravertebral Block (PVTB) for Postoperative Analgesia in Hepatectomy

Not Applicable

Conditions: Hepatectomy
Postoperative Analgesia
Thoracic Paravertebral Block
Quadratus Lumborum Block

Interventions: Other: Patient-controlled intravenous analgesia
Other: Thoracic Paravertebral Block
Other: Quadratus Lumborum Block

First Posted Date: 2018-05-30

Last Posted Date: 2018-10-23

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 180

Registration Number: NCT03540537

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Observational Study on Pregnant Women With Chronic Hepatitis B and Their Infants

Conditions: Hepatitis B, Chronic

First Posted Date: 2018-05-29

Last Posted Date: 2018-05-29

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 1000

Registration Number: NCT03539016

Locations: 🇨🇳
Beijing YouAn Hospital, Beijing, China
🇨🇳
Zhujiang Hospital, Guangzhou, China
🇨🇳
Fifth Affiliated Hospital of Southern Medical University, Guangzhou, China

and more 7 locations

Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT

Phase 2

Conditions: Acute Myeloid Leukemia
Allogeneic Hematopoietic Stem Cell Transplantation
Conditioning
Elderly

Interventions: Drug: Decitabine
Drug: Busulfan (BU)
Drug: Fludarabine(Flu)

First Posted Date: 2018-05-21

Last Posted Date: 2020-12-22

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 60

Registration Number: NCT03530085

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes

Recruiting

Conditions: Type 2 Diabetes Mellitus
Nonalcoholic Fatty Liver Disease (NAFLD)

Interventions: Diagnostic Test: FibroTouch

First Posted Date: 2018-05-16

Last Posted Date: 2018-05-16

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 10000

Registration Number: NCT03525769

Locations: 🇨🇳
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Establishing of an Early Warming System of Premature Ovarian Insufficiency

Conditions: Primary Ovarian Insufficiency

First Posted Date: 2018-05-08

Last Posted Date: 2018-05-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 500

Registration Number: NCT03518944

Locations: 🇨🇳
Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women

Conditions: Primary Ovarian Insufficiency

First Posted Date: 2018-05-08

Last Posted Date: 2018-05-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 50000

Registration Number: NCT03518918

Locations: 🇨🇳
Center for Reproductive Medicine, Department of Gynecology and Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

An Effect and Safety Observation on PELD Technique for Extraforaminal Disc Herniation at L5/S1

Conditions: Neuralgia, Sciatic

Interventions: Procedure: PELD operation

First Posted Date: 2018-04-27

Last Posted Date: 2021-02-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 30

Registration Number: NCT03511456

Locations: 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China

Home Terms & Conditions Privacy Policy